Skip to content

Psychedelic-assisted therapy: all studies

Page 125 of 294: studies 1,241 to 1,250 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Meeting Grandmother: Breakdown, breakthrough, and the fear of madness in psychedelic research

Psychedelics May 16, 2026 Tam Martin Fowles, Tehseen Noorani

We take a wide view across the emerging research into psychedelics and psychosis/madness, to emphasize the need for not just more but also wise research at these intersections. We note the growing rate of publications on the use of psychedelics by people who have had experiences of psychosis/madness, and make our arguments around a narrative report of the lead author, who experienced a...

DOI: 10.1016/j.psyche.2026.100022 (opens in new tab) Anxiety Unconscious mind Action physics Perspective graphical +1

Variability in outcomes and subjective effects of psychedelic use in psychotic populations: Case-based evidence from naturalistic settings

Psychedelics May 14, 2026 Joseph T. la Torre, Jade Gallo, Matteo Buonaroti et al.

This paper presents qualitative data reported by individuals with histories of psychotic symptoms and experiences who engaged in naturalistic psychedelic use compiled as a case series. Through detailed first-person narratives, we explore how both classic and non-classic psychedelic experiences were subjectively experienced and integrated by individuals in this population, which is usually...

DOI: 10.1016/j.psyche.2026.100021 (opens in new tab) Qualitative research Categorical variable Naturalism Naturalistic observation +5

CONTRIBUIÇÕES DOS PSICODÉLICOS PARA A PSICOTERAPIA DA ANSIEDADE: PERSPECTIVAS ATUAIS

ULAKES JOURNAL OF MEDICINE May 13, 2026 Maria Eduarda Marquezi Machioni, Giulia Argueles de Oliveira, Ana Luísa da Silva Rueda et al.

Diante da crescente prevalência dos diagnósticos de transtornos ansiosos no Brasil e no mundo, o presente artigo visa analisar as contribuições das substâncias psicodélicas no tratamento dos transtornos. Por meio de uma revisão narrativa, foram examinados estudos sobre o potencial terapêutico de compostos como LSD, psilocibina, ayahuasca e MDMA. Os resultados colhidos apontam que essas...

DOI: 10.56084/ulakesjmed.v6i1.1495 (opens in new tab) Context archaeology Perspective graphical Subject documents Argument complex analysis +2

Psychedelika in der Psychotherapie: Von der pharmakologischen Wirkung zur transdiagnostischen Veränderung

Suchttherapie May 12, 2026 Susanne Prinz, Helena Aicher

Zusammenfassung Die Psychedelika-assistierte Therapie (PAT) hat sich in den letzten Jahren zu einem der dynamischsten Forschungsfelder der Psychiatrie entwickelt. Während die beste Evidenz bisher für depressive Störungen und posttraumatische Belastungsstörungen vorliegt, wird PAT zunehmend auch bei anderen nicht-psychotischen Störungen untersucht. Jenseits der Symptomlinderung rückt die...

Depressions- und Angstsymptome nach psychedelisch-assistierter Psychotherapie bei therapieresistenter Depression: retrospektive Routinedatenanalyse mit vs. ohne komorbide Substanzkonsumstörung

Suchttherapie May 12, 2026 Louise Penzenstadler, Tatiana Aboulafia Brakha, Daniele Zullino

Zusammenfassung Substanzkonsumstörungen (SUD) sind chronische Erkrankungen mit hohen Rückfallraten und begrenzter Wirksamkeit etablierter Behandlungen. Vor diesem Hintergrund rückt die psychedelisch-assistierte Psychotherapie (PAP) mit Psilocybin und LSD zunehmend in den Fokus; die Literatur berichtet Hinweise auf mögliche Effekte insbesondere bei AUD und affektiven Symptomen. Ziel der Studie:...

Psychedelic Use and Psychological Healing Among Gender Exploring Clients: Clinicians’ Perspectives

Women & Therapy May 12, 2026 Esenia K. Cassidy, Juliana Riccardi, Britt Healy et al.

Background The use of psychedelics for clinical purposes and psychological healing is well-documented across many settings, often addressing trauma or mood disorders. Two gaps remain underexplored: (1) the use of psychedelics for psychological healing by gender-diverse individuals, and (2) the personal therapeutic use of psychedelics in non-clinical settings and how this shows up in...

DOI: 10.1080/02703149.2026.2667141 (opens in new tab) Gender identity Affect linguistics Qualitative research Psychological distress +3

Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care

Premier Journal of Neuroscience May 11, 2026 Khadija Kamene

Background: Treatment-resistant depression (TRD) affects a significant proportion of individuals with major depressive disorder and remains difficult to manage with conventional treatments. Psychedelic-assisted therapies and neuromodulation have emerged as innovative interventions targeting neurobiological mechanisms beyond traditional antidepressant approaches. Objectives: This scoping review...

Nondual awareness as a novel chronic pain-relieving mechanism.

Psychology of Consciousness Theory Research and Practice May 11, 2026 Kush V. Bhatt, Adam W. Hanley, Chantal Martin-Soelch et al.

Mindfulness-based interventions are efficacious nonpharmacologic treatments for chronic pain, yet the psychological mechanisms mediating the pain-relieving effects of mindfulness-based interventions remain incompletely understood. One potential mechanism may involve nondual awareness, a state of consciousness characterized by attenuation of the subject-object duality, reduced self-referential...

DOI: 10.1037/cns0000474 (opens in new tab) Perspective graphical Disease Medline Identification biology

Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review

Research Square May 11, 2026 Chloë K Walters, Sarentha Chetty, Thankhoe A Rants’o et al. preprint

Abstract Background: Conventional pharmacotherapy for treatment-resistant depression (TRD) has been found to provide limited benefit in a subset of patients. Psilocybin‑assisted therapy has emerged as a promising modality due to its rapid‑acting antidepressant effects and favourable tolerability profile shown in early trials. Despite growing research interest in psilocybin‑assisted therapy the...

From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice

Pharmacology Research & Perspectives May 10, 2026 Jessie Kim, Liam Lochhead, Cory R. Weissman

Interest in psychedelic-assisted therapy (PAT) is surging across research and medical communities, prompting the discussion of policy shifts that reflect growing openness to implementing psychedelics in clinical practice. State-level psychedelic reform in the United States has accelerated since 2019, with legalization projected to reach most states within the next decade if trends follow those...

DOI: 10.1002/prp2.70262 (opens in new tab) Legalization Clinical trial Mainstream Inclusion mineral +12